Life Spring Forum on Trastuzumab Discovery
Dedicated to 20th Anniversary of
Dr. H. Michael Shepard's
Science with Life Saving on Breast Cancer
-one Magic Bullet Saves Million of Women's Life &
Celebrating 45th Anniversary of the First Monoclonal Antibody was Generated in 1975
Program Layout
Time: September 19-22, 2021
Place: Dalian International Conference Center, Dalian, China
Registration | |
Time: 09:00-22:00, September 18, 2021 (Friday); Place: DICC, Dalian, China | |
Opening Ceremony & Plenary Summit | |
Time: 09:00-12:00, September 19, 2021 (Saturday); Place: Room 308, DICC, Dalian, China | |
Life Sprinting Forum | |
Time: 14:00-17:30, September 19, 2021 (Saturday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
14:00-14:10 | Chair's Introduction |
14:10-14:40 |
Opening Remarks Welcome Introduction to the Event |
14:40-15:10 | Opening Speech |
15:10-15:30 | Coffee Break |
15:30-16:30 | 3-4 Sponsorship Presentations |
16:30-17:30 | Discussion |
Session One: The Target-Her2 and Breast Cancer | |
Time: 08:30-12:00, September 20, 2021 (Sunday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
08:30-08:40 | Chair's Introduction |
08:40-09:10 | Invited Speech |
09:10-09:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:30-09:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:50-10:20 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:20-10:30 | Coffee Break |
10:30-10:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:50-11:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:10-11:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:30-12:00 | Sponsorship Presentation |
Session Two: Story of Discovering Herceptin | |
Time: 13:30-17:30, September 20, 2021 (Sunday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
13:30-13:40 | Chair's Introduction |
13:40-14:10 | Invited Speech |
14:10-14:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:30-14:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:50-15:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:10-15:30 | Coffee Break |
15:30-15:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:50-16:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:10-16:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:30-16:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:50-17:20 | Sponsorship Presentation |
17:20-17:30 | Discussion |
Session Three: New Advances of Hybridoma Technique | |
Time: 08:30-12:00, September 21, 2021 (Monday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
08:30-08:40 | Chair's Introduction |
08:40-09:10 | Invited Speech |
09:10-09:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:30-09:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:50-10:20 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:20-10:30 | Coffee Break |
10:30-10:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:50-11:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:10-11:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:30-12:00 | Sponsorship Presentation |
Session Four: The History and Development of Monoclonal Antibody | |
Time: 13:30-17:30, September 21, 2021 (Monday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
13:30-13:40 | Chair's Introduction |
13:40-14:10 | Invited Speech |
14:10-14:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:30-14:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:50-15:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:10-15:30 | Coffee Break |
15:30-15:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:50-16:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:10-16:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:30-16:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:50-17:20 | Sponsorship Presentation |
17:20-17:30 | Discussion |
Session Five: The Future of Cancer Immunotherapy | |
Time: 08:30-12:00, September 22, 2021 (Tuesday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
08:30-08:40 | Chair's Introduction |
08:40-09:10 | Invited Speech |
09:10-09:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:30-09:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
09:50-10:20 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:20-10:30 | Coffee Break |
10:30-10:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
10:50-11:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:10-11:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
11:30-12:00 | Sponsorship Presentation |
Session Six: Antibodies Lead the Way to CAR-T Therapy | |
Time: 13:30-17:30, September 22, 2021 (Tuesday); Place: Room 304, DICC, Dalian, China | |
Chair | Call for Chair |
Co-Chair | Call for Co-Chair |
13:30-13:40 | Chair's Introduction |
13:40-14:10 | Invited Speech |
14:10-14:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:30-14:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
14:50-15:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:10-15:30 | Coffee Break |
15:30-15:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
15:50-16:10 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:10-16:30 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:30-16:50 |
Speech Opportunity Available Abstract and Biography: Submit Here |
16:50-17:20 | Sponsorship Presentation |
17:20-17:30 | Discussion |